3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
85
Lung Neoplasms
29
Neoplasms
7
Neoplasm Metastasis
7
Carcinoma
5
Colorectal Neoplasms
4
NSCLC
3
Breast Neoplasms
3
Brain Neoplasms
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Non Small Cell Lung Cancer Metastatic
2
Multiple Myeloma
2
Meningeal Carcinomatosis
2
Lymphoma
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stage II-IIIB Non-small Cell Lung Carcinoma
1
Stage IB-IIIA Non-small Cell Lung Carcinoma
1
Solid Tumor, Adult
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Interventions
pembrolizumab
16
Nivolumab
15
Ipilimumab
12
cemiplimab
10
aldesleukin
6
Interleukin-2
6
Cyclophosphamide
6
fludarabine
5
fludarabine phosphate
4
encorafenib
4
binimetinib
4
Blood Specimen Collection
4
avelumab
3
Sirolimus
3
trametinib
2
spartalizumab
2
lifileucel
2
dabrafenib
2
atezolizumab
2
Vemurafenib
2
Surgical Procedures, Operative
2
Specimen Handling
2
Radiotherapy
2
Prednisone
2
Niacinamide
2
Exercise
2
Everolimus
2
Dermoscopy
2
Biopsy
2
urelumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
osimertinib
×
1 year
×
Clear all
No trials found.